Serine-arginine protein kinase 1 (SRPK1) inhibition as a potential novel targeted therapeutic strategy in prostate cancer. (2015)

First Author: Mavrou A

Attributed to: Regulation of VEGF splicing funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/onc.2014.360

PubMed Identifier: 25381816

Publication URI: http://europepmc.org/abstract/MED/25381816

Type: Journal Article/Review

Volume: 34

Parent Publication: Oncogene

Issue: 33

ISSN: 0950-9232